Ingersoll Rand Inc IR

Thesis

Ingersoll Rand sells the unglamorous machines that move air, gas, and liquid: rotary screw compressors, vacuum pumps, blowers, precision metering pumps, and the aftermarket parts and service that follow them for 15-20 years. The thesis is structurally simple: highly fragmented end markets, customers that cannot tolerate downtime on a $2,000 compressor that supports a $20 million production line, and a roll-up engine (IRX) that has bought 9+ businesses in 2025 alone (SSI Aeration, Excelsior, Cullum-Brown, GD Chillers, LeadFluid, Termomeccanica, Dave Barry Plastics, Transvac, Friulair). Two segments — Industrial Technologies & Services (ITS) and Precision & Science Technologies (P&ST) — both throw off recurring aftermarket revenue that is roughly 35-40% of sales and substantially higher margin than original equipment.

The scorecard tells a split story. The 5-year ROIIC of 63.2% is exceptional and reflects the post-Gardner-Denver-merger margin expansion plus accretive M&A; but the 10-year average ROIC of only 5.54% reminds us that goodwill from past deals weighs on the denominator. Net debt/EBITDA is -0.71 (net cash), so the balance sheet is a weapon, not a constraint. Share count is up 13.4% over a decade, mostly from the 2020 Gardner Denver merger. TTM owner earnings are $775M, P/E is 38.5x, and reverse-DCF implied growth is 13.4% — a number IR has hit recently but cannot extrapolate forever.

At $77.99 against IV_base $81.67, P/IV is 0.95. The stock is fair, not cheap. I want a 25-30% margin of safety on a roll-up where maintenance capex is uncertain and the base CAGR was clamped from 55% to 14%. Buy under $60; trim above $106.

Moat

Ingersoll Rand's moat is best described as a bundle of small, local moats stacked on top of a logistics-and-service network. It is real, but it is narrow.

Cost advantages — moderate. IR is the global volume leader (or co-leader with Atlas Copco) in rotary-screw and centrifugal industrial air compressors. Volume drives unit cost on castings, motors, and controls. More importantly, it drives density of the field-service footprint. A compressor down on a Tuesday afternoon at a bottling plant must be back up Wednesday morning, and only a vendor with technicians within a 90-minute drive can credibly promise that. Atlas Copco, Kaeser, and Sullair all have similar density in different geographies; this is a stalemate, not a one-sided advantage. Buffett's observation that "buy commodities, sell brands" produces sustained profits applies imperfectly here [4] — the brand premium is real on aftermarket parts and service, weaker on new equipment.

Switching costs — moderate to high in aftermarket. Once a customer specifies an Ingersoll Rand or Gardner Denver compressor into a plant, the maintenance contract, OEM-spec consumables (filters, oil, separators), and trained technicians create real friction. Ripping out installed iron is expensive and disruptive. This is the ROIIC engine: 35-40% of segment revenue is recurring aftermarket, with gross margins materially above OEM. The switching cost is per-asset, not per-customer — losing the next new compressor sale is easy; losing the existing fleet is hard.

Intangibles — narrow. The Ingersoll Rand and Gardner Denver names matter to plant engineers and procurement officers in a "nobody got fired for buying IBM" way. They do not matter to end consumers. Patents on individual compressor designs exist but expire; the technology is mature. The real intangible is institutional knowledge — sizing, application engineering, and the specification-and-service relationship — and that is held mostly in the heads of the field force.

Pricing power — limited but real. IR has demonstrated 2-4% annual price increases through the 2021-2023 inflation cycle without losing share, which is more than commodity producers can do. But customers are sophisticated industrial buyers with engineered alternatives. The price umbrella is a few percent, not the 10-15% Coca-Cola or See's enjoy.

Network effects — none. Compressors do not become more useful as more of them are sold.

$10B / 5-year stress test. If a competitor — say, a Chinese state-backed industrial group — committed $10B over five years to buy share, what happens? They could undercut on OEM pricing in emerging markets and probably take 5-10 points of share there. They would struggle to replicate the Western service network in less than a decade; Buffett's Iscar analogy fits — "the world's two other leading suppliers of small cutting tools both had very difficult years" while Iscar kept compounding [1]. The aftermarket annuity on existing installed base is mostly safe for the duration of the equipment life (15-20 years). New OEM share is not safe.

Erosion risks. Three: (1) heat pumps, electrification, and industrial decarbonization could shift the application mix faster than IR's product roadmap; (2) hyperscaler data-center cooling — currently a tailwind — is a fashion that could reverse; (3) the roll-up math fails when good targets at reasonable multiples run out, forcing either pricier deals or a return of capital. The 10-year ROIC of 5.54% is the past; the 5-year ROIIC of 63% is the present; the question is which one is the future.

Moat verdict: NARROW.

Management & Capital Allocation

Ingersoll Rand's modern history begins with the February 2020 merger of legacy Ingersoll-Rand's industrial segment with Gardner Denver, executed under CEO Vicente Reynal and his team. Reynal brought the IRX operating system — a Danaher Business System analogue that emphasizes daily management, kaizen, 80/20 segmentation, and disciplined M&A integration — and applied it to a combined business with substantial cost-synergy headroom. The post-merger margin expansion is real and is the source of the 63.2% 5-year ROIIC.

Reinvestment. Organic capex runs roughly 2% of sales — modest, appropriate for a mature manufacturing business. R&D is similarly modest at ~3% of sales, weighted toward digital connectivity (compressor monitoring, predictive maintenance) and adjacencies (life sciences pumps). The reinvestment rate is low because the core business does not need much; this is correct, not lazy.

Acquisitions. This is the headline capital-allocation activity. The 10-K lists at least nine 2025 closings: SSI Aeration, Excelsior Blower Systems, Cullum & Brown of Kansas City, GD Chillers, LeadFluid (China), Termomeccanica (Italy), Dave Barry Plastics, Transvac (UK), and the prior-year Friulair. Average deal size appears to be $50-300M — bolt-ons, not bet-the-company deals. The pattern parallels Buffett's praise of Frank Ptak at Marmon: "Frank regularly makes bolt-on acquisitions that, in aggregate, will materially increase Marmon's earning power" [4]. Reynal's deals appear to be priced at 12-15x EBITDA pre-synergy and 8-10x post-synergy — not steals, but not destructive either. The 5-year ROIIC of 63.2% is the receipt that says the math has worked. The 10-year ROIC of 5.54% is the reminder that goodwill carries forward forever.

Debt. Net debt/EBITDA of -0.71 means the company carries net cash. That is a fortress balance sheet for an industrial cyclical and is a deliberate choice — Reynal has stated he wants dry powder to lean into M&A during downturns when sellers capitulate. This is the right posture for a serial acquirer; it is also the posture that allowed the 2025 deal cadence.

Buybacks. Modest. The company has bought back stock opportunistically but not aggressively. Share count is up 13.4% over 10 years, almost entirely from the Gardner Denver merger (issued, not bought). On a post-merger basis, share count has been roughly flat to slightly up. There is no evidence of buying back stock at attractive prices to IV — Buffett's gold standard. This is a B, not an A.

Dividends. Token: a quarterly dividend yielding well under 1%. The signal is that management would rather acquire than return capital, which is internally consistent with the high-ROIIC story but means shareholders cannot easily harvest cash without selling.

Communication quality. Investor day decks are clear and quantitative. Management talks in IRR terms about acquisitions, publishes deal-by-deal synergy targets, and tracks against them. They do not over-promise on macro. The tone is more Danaher than Tyco — measured, operational, financially literate. Buffett's note that "goals should be (1) tailored to the economics of the specific operating business; (2) simple in character so that the degree to which they are being realized can be easily measured" [2] describes the IRX scorecards reasonably well.

The honest critique. The 10-year ROIC of 5.54% is uncomfortably low for a Buffett-Munger compounder. Most of management's case rests on the post-2020 record. Five years of IRX execution does not yet prove a 25-year compounder. Reynal could leave; the IRX flywheel could falter; the deal pipeline could dry up. Insider ownership is modest (low single-digit percent), so skin-in-the-game is not Berkshire-grade.

Capital allocator: B.

Industry Structure

Industrial flow-control equipment — air compressors, vacuum pumps, blowers, precision pumps — is a mature, fragmented, globally competitive industry with attractive but not exceptional structural economics.

Buyer power — moderate. End customers are industrial manufacturers, hospitals, semiconductor fabs, water-treatment operators, food and beverage plants, and data centers. Most are sophisticated and run RFPs on new equipment. They are price-sensitive on OEM and price-insensitive on aftermarket parts where downtime cost dwarfs the bill. The bifurcation is structural and lasting: OEM is a competitive tender; aftermarket is a near-monopoly per asset. Large buyers (semiconductor fabs, hyperscalers) have meaningful leverage; the long tail of mid-market plants does not.

Supplier power — low. Inputs are castings, motors, controls, electronics, and steel. All are commoditized and globally sourced. IR's scale gives it the buy-side, not the sell-side, advantage on inputs.

Threat of new entrants — low to moderate. Building a credible global compressor business from scratch requires (a) a multi-decade installed base for aftermarket annuity, (b) a global service network with thousands of trained technicians, and (c) regulatory certifications across dozens of jurisdictions. None is impossible, but the capital and time barriers are real. Chinese state-backed groups can and do enter at the low end (LeadFluid, which IR itself acquired, suggests some are buyable). The risk is more share erosion in emerging markets than displacement in OECD.

Threat of substitutes — moderate, slow-moving. Compressed air is sometimes replaceable with electric actuation. Vacuum pumps in some lab applications can be replaced by alternative technologies. Industrial decarbonization is the longest-dated headwind, but compressed air is fundamental to manufacturing and will not disappear in a decade. Buffett's caution about "depressed industrial sector" exposure [1] is real but cyclical, not existential.

Rivalry — moderate. The top 4-5 players (Atlas Copco, Ingersoll Rand, Kaeser, Hitachi/Sullair, Gardner Denver legacy brands now consolidated under IR) act rationally. They compete on product and service rather than on price wars. Below the top tier, hundreds of regional players exist — the consolidation runway IR is harvesting. Atlas Copco is the most disciplined and arguably the best-run competitor; it sets the ceiling on IR's pricing power.

Value pool location and trajectory. The aftermarket is where 60-70% of segment profits live, on roughly 35-40% of revenue. This pool is sticky and growing modestly with installed base. New-equipment value pool grows with industrial capex cycles — currently elevated by data-center cooling demand and reshoring/onshoring capex. The risk: a 2009-style industrial recession would compress new-equipment volumes 25-35% in a year, with aftermarket holding up far better. Net-net the value pool is durable.

Industry Verdict: Good.

Inversion (Bear Case)

I am now the short-seller. My job is to sketch the credible bear case without softening.

The single event that kills this. A 2008-2009-style global industrial recession arrives in 2026-2027. Manufacturing PMI prints below 45 for six consecutive months. Industrial capex falls 20-30%. New-equipment orders for compressors and vacuum pumps drop 30-40% peer-wide. IR's revenue contracts 18-22%, EBITDA contracts 30-35% (operating leverage), free cash flow halves. The acquisition pipeline freezes because sellers won't capitulate fast enough at multiples that work. The stock, which trades at 38.5x TTM earnings on a 13.4% implied growth assumption, re-rates to 18x earnings on 5% expected growth. That is roughly $40 — below IV_low of $45.17. Buffett's 1984 reminder about industries where managers "have engaged in various transactions to hide true current loss costs" [3] is not literally about IR, but the pattern of rolling up at expensive multiples and hoping growth covers the goodwill is a distant cousin.

Why the moat is narrower than bulls think. Bulls anchor on aftermarket attach rates and service density. Both are real and both have ceilings. Aftermarket is per-asset — it does not grow if installed base shrinks, and installed base shrinks in a deep capex recession. Service density is geographic — IR has it in North America and Europe; Atlas Copco has it in equal or better measure in Europe and Asia; Chinese state-backed players are building it in Asia and emerging markets. The "NARROW" moat verdict is generous. On a 25-year horizon, the 10-year ROIC of 5.54% is the more honest signal than the 5-year ROIIC of 63.2%, and 5.54% is below cost of capital. A business that earned below cost of capital for a decade is not a Buffett compounder; it is a cyclical industrial that is currently in a good cycle.

Why management is worse than it appears. Reynal and his team are good operators. They are not yet proven capital allocators in a downturn. The IRX system is real, but it is a process; processes do not make bad multiples good. The 2025 deal cadence — nine bolt-ons in twelve months — is exactly the cadence one would expect at a cycle peak when sellers' multiples are elevated. The honest pre-mortem question: how many of those nine deals will earn their cost of capital through a full cycle? The probable answer is six or seven, not all nine. Goodwill on the balance sheet has compounded; the 5.54% 10-year ROIC reflects that goodwill drag, and it will not improve. Insider ownership is low single-digit percent; skin in the game is professional, not proprietorial. Buffett's 2001 warning about General Re — "if winning is equated with market share rather than profits, trouble awaits" [3] — is the bear-case analogy, not a fact, but it is a real risk pattern in serial acquirers.

What bulls are extrapolating that won't hold. Three things. First, post-merger synergy capture is largely done; 2026-2028 organic margin expansion will be 50-100bps per year, not the 200-300bps of the 2021-2023 catch-up. Second, the 13.4% reverse-DCF implied growth assumes both organic mid-single-digit growth and accretive M&A continues at current pace; either alone is plausible, both together for a decade is heroic. Third, hyperscaler data-center cooling demand — currently a meaningful tailwind — is a fashion-of-the-cycle, not a permanent regime; capex cycles in tech infrastructure historically overshoot and correct. The base CAGR was clamped from 55% to 14% by the scorer, which is itself an admission that the recent compounding rate is not extrapolatable.

Valuation trap (multiple compression / regime change). TTM P/E is 38.5x against a 10-year average of 128.97x — wait, that 10-year average is distorted by recovery-from-loss years and is not a useful comparable. The honest comparables: peer Atlas Copco trades at ~28x earnings; Roper, the gold-standard serial acquirer, trades at ~30x; Watts Water ~25x. IR at 38.5x is at a premium to the peer set. If sentiment normalizes IR to 25-28x earnings on $2.00-2.20 of normalized EPS, the stock is $50-60. If a recession compresses earnings to $1.50 and the multiple to 20x, the stock is $30. The asymmetry is unfavorable from $77.99: limited upside because IV_high is only $106 (36% gain), substantial downside because IV_low is $45 (42% loss) and the cycle case is below that.

If I am right, the stock could be worth $40-50 within 18-30 months.

Lollapalooza Bias Check

Active biases I should name out loud:

Recency bias. The 5-year ROIIC of 63.2% is recent and dazzling. The 10-year ROIC of 5.54% is older and duller. My system-1 reaction is to weight the recent number more, because it is vivid and tells a clean story (post-merger IRX excellence). The Buffett discipline says weight the longer record more, because cycles play out over 10-20 years and the long record captures more variance. I am consciously dialing back the ROIIC enthusiasm and dialing up the 10-year ROIC sobriety.

Authority bias. Vicente Reynal is widely admired in industrial-cap circles, gets covered by sell-side as a top-tier operator, and is compared to Larry Culp's tenure at Danaher. Authority bias says: if smart people I respect call him excellent, he must be excellent. The check: I have not personally verified his capital-allocation discipline through a downturn. The 2020 Gardner Denver merger was negotiated pre-COVID and integrated during a strong industrial cycle. He has not yet been tested in a deep recession. The verdict "B" rather than "A" reflects this discount.

Anchoring on price. P/IV of 0.95 is suspiciously close to par. I notice my mind wanting to round 0.95 up to "basically fair value, why not own it." The Buffett discipline says par is not a buy point; 0.65-0.75 is. I am consciously adjusting the buy point well below current price ($60) rather than splitting the difference.

Story bias. "Roll-up of mission-critical industrial-air equipment with proven IRX operating system" is a clean, three-act narrative. Clean narratives are seductive and often wrong in their tails. The check: a good roll-up at the wrong price is still a bad investment, and the moat-stress test produces a NARROW verdict, not WIDE. The story is good enough to keep watching, not good enough to override the price discipline.

Confirmation bias. Once I started writing the bull thesis, I noticed I was reading the 9 bolt-on acquisitions as evidence of "a well-oiled M&A machine" rather than "deal-cadence acceleration at a cycle peak." Both readings are defensible. The inversion section is the deliberate counterweight.

Commitment / consistency. None active — no prior position to defend, no public call to support.

Deprival super-reaction. Mild. The stock is near IV; if it runs to IV_high in the next year I will have missed a 36% move. The Buffett discipline says: better to miss than to overpay. I am consciously accepting the miss risk.

10-Year Outlook

Will Ingersoll Rand look fundamentally similar in 2036?

Same business model? Yes, with high probability. Industrial customers will still need to move air, gas, and liquid; the equipment will be more digitally instrumented but mechanically similar; aftermarket service will still be 35-40% of sales and the profit anchor. This is a 100-year-old industry that will be a 110-year-old industry.

Customer base larger? Probably. Industrial output globally grows with GDP plus reshoring tailwinds in OECD. Data centers, life sciences, water treatment, and semiconductor fabs are net adds to the addressable installed base. Decarbonization is a mixed signal: some pneumatic applications electrify away, others (hydrogen handling, carbon capture) become new compressor demand. Net-net, the customer base is modestly larger.

Profit per customer higher? Plausibly. Aftermarket attach rates can rise 5-10 percentage points with connected-equipment monetization (predictive maintenance subscriptions, remote diagnostics). Pricing keeps up with inflation plus a modest spread. The probable trajectory is operating margin expansion of 200-400bps over a decade, gated by competitive response from Atlas Copco.

Moat wider? No, probably the same width. Service density compounds slowly; competitors are not standing still. The roll-up of regional players continues to widen IR's relative scale advantage, but the absolute moat boundary is set by Atlas Copco's discipline, not by IR's effort.

Single biggest threat. A multi-year industrial recession that compresses earnings, freezes the M&A pipeline at the wrong moment, and forces the market to re-rate the business from a roll-up multiple to an industrial-cyclical multiple. Distant second: Chinese competitors moving up-market in compressor and pump technology faster than expected.

The 12-year-old test passes. The business is explainable, the drivers are durable, the technology is mature. I do not need to predict regulatory outcomes, consumer fads, or a specific R&D breakthrough. I do need to predict the industrial capex cycle and the capital-allocation discipline of one CEO. Both are knowable but uncertain.

CONFIDENCE: medium